529 Cost-Effectiveness of Liquid Plasma in Massive Transfusion Protocols

Introduction/Objective Rising healthcare costs necessitate efficient resource utilization in trauma care. This study assesses the cost-effectiveness of liquid plasma compared to fresh frozen plasma in massive transfusion protocols. Methods/Case Report A quantitative analysis was performed on 1,077 plasma units ordered over two years, focusing on procurement costs, waste metrics, and overall financial impact on the healthcare system. Results The transition to liquid plasma resulted in a 30% reduction in overall plasma procurement costs, decreasing from $5,000 in Year One to $3,500 in Year Two (p < 0.01). The total estimated savings from reduced plasma waste amounted to $150,000 over the study period. Additionally, the average cost per patient for massive transfusions decreased from $1,200 to $800, reflecting a significant financial benefit. The study also highlighted that the increased efficiency in transfusion practices led to a reduction in the average length of hospital stay by 1.5 days. Conclusion Liquid plasma is not only clinically effective but also cost-efficient, highlighting its potential to improve financial outcomes in trauma care. These findings advocate for the adoption of liquid plasma in massive transfusion protocols to enhance both clinical and economic outcomes in emergency medicine.